BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10427644)

  • 1. Osteoporosis management: physicians' recommendations and womens' compliance following osteoporosis testing.
    Cole RP; Palushock S; Haboubi A
    Women Health; 1999; 29(1):101-15. PubMed ID: 10427644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis.
    J Fla Med Assoc; 1996 Oct; 83(8):552-66. PubMed ID: 9160000
    [No Abstract]   [Full Text] [Related]  

  • 3. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR; Shrader SP; Ragucci KR
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The osteoporosis care gap in Canada.
    Papaioannou A; Giangregorio L; Kvern B; Boulos P; Ioannidis G; Adachi JD
    BMC Musculoskelet Disord; 2004 Apr; 5():11. PubMed ID: 15068488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment.
    Solomon DH; Levin E; Helfgott SM
    J Rheumatol; 2000 Jun; 27(6):1496-500. PubMed ID: 10852277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis management.
    Rozenberg S; Vandromme J; Ayata NB; Filippidis M; Kroll M
    Int J Fertil Womens Med; 1999; 44(5):241-9. PubMed ID: 10569453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis in women.
    Bowman MA; Spangler JG
    Prim Care; 1997 Mar; 24(1):27-36. PubMed ID: 9016728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic strategies for osteoporosis].
    Chapurlat R; Delmas PD
    Ann Med Interne (Paris); 2000 Oct; 151(6):471-6. PubMed ID: 11104926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New possibilities for diagnosis and treatment of osteoporosis.
    Miller PD
    Int J Fertil Womens Med; 2001; 46(4):215-21. PubMed ID: 11563832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of life of patients suffering from osteoporosis treated with alendronate and salmon calcitonin].
    Sapuła RA; Ostrowski T; Bojar I
    Wiad Lek; 2002; 55 Suppl 1():444-7. PubMed ID: 15002282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of osteoporosis and fractures.
    Ullom-Minnich P
    Am Fam Physician; 1999 Jul; 60(1):194-202. PubMed ID: 10414638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postmenopausal osteoporosis].
    László A
    Orv Hetil; 2004 Jan; 145(1):3-13. PubMed ID: 15222134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis: handy tools for detection, helpful tips for treatment.
    Morgan SL; Kitchin B
    J Fam Pract; 2008 May; 57(5):311-20. PubMed ID: 18460296
    [No Abstract]   [Full Text] [Related]  

  • 19. What to do about postmenopausal fracture risk. Diet, exercise, calcium, and vitamin D are always important, but women at high risk for fractures may need drug therapy, too.
    Harv Womens Health Watch; 2009 Dec; 17(4):1-3. PubMed ID: 20088086
    [No Abstract]   [Full Text] [Related]  

  • 20. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
    Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.